Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee

Life Science

Tech Tumbles as SpaceX Leads Selloff — These Two Dividend Kings Offer Calm Amid the Chaos

Consumer Goods, Technology

China Adds MP Materials, USA Rare Earth to Export Blacklist in Tit-for-Tat Move

Mining

Micron’s 260% Rally Faces Earnings Test as AI Memory Boom Enters New Phase

Technology

Vietnam’s Masan Expands Tungsten Mine as China Supply Curbs Draw Global Capital

Mining

Before Betting on Falling Oil, Read What Exxon and Chevron Just Told Investors

Energy

Grail Missed Its Endpoint, But Investors May Have Missed the Real Story

Life Science

What the SpaceX IPO Teaches Investors About the Coming Anthropic and OpenAI Offerings

Technology

VOO vs. RSP: The Hidden Risk in Buffett’s Go-To S&P 500 ETF That Most Investors Miss

Financial Service, Technology

AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths

Life Science, Technology

Nvidia and Intel Rallied Too Much, Broadcom Is the AI Chip Bargain Investors Need

Technology

Weekly Market Recap (June 19) -JPMorgan: Buy Gold on Dips

Precious Metals

After a 27% Plunge and a $500 Downgrade, Is Gold’s Multi-Year Rally Done?

Precious Metals

Beyond SpaceX: Canada’s MDA Space Emerges as a Compelling Space Play With $620M Blue Canyon Buyout

Technology

Nuclear Power’s Global Boom Is Here, These Two U.S. Stocks Are Well Positioned

Energy